Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.

导出 LinkOut

翻译打印收藏纠错

第一作者： Szilárd,Kiss

第一单位： Weill Cornell Medical College, New York, NY, USA.

作者： Szilárd,Kiss ^[1] ; Ruslan,Grishanin ^[2] ; Aivan,Nguyen ^[2] ; Romeo,Rosario ^[2] ; Judith S,Greengard ^[2] ; Julio,Nieves ^[2] ; Claire M,Gelfman ^[2] ; Mehdi,Gasmi ^[2]

作者单位： Weill Cornell Medical College, New York, NY, USA. ^[1] Adverum Biotechnologies, Menlo Park, CA, USA. ^[2]

DOI 10.1016/j.omtm.2020.06.007

PMID 32671137

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular therapy. Methods & clinical development

2020年18卷

345-353页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.

Molecular therapy. Methods & clinical development

相似文献

Molecular therapy. Methods & clinical development

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Analysis of Aflibercept Expression in NHPs following Intravitreal Administration of ADVM-022, a Potential Gene Therapy for nAMD.

Molecular therapy. Methods & clinical development

相似文献

Molecular therapy. Methods & clinical development

相关期刊

检索历史清除